Equashield’s robotic technology can help transport and handle dangerous drugs in hospital and healthcare facilities.
News & Features
Neural Analytics has received CE mark and FDA clearance for a robotics-based ultrasound guidance system to observe blood flow to the brain.
Roche agreed to pay $2.4 billion to acquire the remaining shares of Foundation Medicine, a company that develops genomic profiling assays to pair cancer patients with relevant treatments and clinical trials.
A Massachusetts jury backed Boston Scientific in a product liability case involving two of the company's transvaginal mesh devices.
FDA granted a de novo request for DreaMed Diabetes' Advisor Pro, an AI-based diabetes treatment decision support software.
An FDA advisory committee concluded that BTG's device for treating severe emphysema patients is safe, but the panel raised concerns about the product's efficacy and whether or not the benefits outweigh the risks.
Philips said it will acquire Remote Diagnostic Technologies in an effort to expand its Therapeutic Care Business.
Arda Ural of Ernst and Young says there are favorable conditions going on in the medtech industry that could help lead to more acquisitions in the space.
By 2020, new medical device products distributed within Europe must comply with the new European Medical Device Regulation. Is your company ready?
We want to raise the profile of the young people doing groundbreaking work in the medical device and diagnostic industry. Do you know any industry innovators under the age of 30? Tell us who should make the 2018 list! Email nominations to [email protected] with the subject line: Medtech's...
Sirtex Medical said farewell to Varian on Thursday and hitched its wagon to CDH Investments, which had launched a competing bid for Sirtex in May.
OmniVision revealed two new partnerships at MD&M East that will help propel it further into the ever-changing healthcare market.